NCT05275101

Brief Summary

The current study is a clinical trial, meaning a research study in which human subjects are prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related behavioral outcomes. Specifically, male and female adults with current suicidal intent will be randomly assigned to receive either a 1-hour session of crisis response planning (CRP) or a 1-hour session of standard crisis risk management (Treatment as Usual). The effects of both conditions on changes in emotion regulation, behavioral inhibition, stress reactivity, and suicide risk will be evaluated post-intervention and at six-month follow-up. Additional assessments of changes in mood and suicidality will be collected daily during the first 10-days following intervention, and then monthly for a duration of six months. A cohort of healthy controls is included in the study but are not randomized to either treatment condition. The investigators hypothesize the following: 1) A single session of CRP will acutely change suicide risk and 2) Individuals who receive CRP will show sustained improvements in measures of suicidality when compared to individuals who received the Treatment as Usual intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
191

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 28, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 11, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2026

Completed
Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

4.6 years

First QC Date

February 10, 2022

Last Update Submit

April 24, 2026

Conditions

Keywords

Suicide PreventionCrisis Response PlanningSuicidefunctional magnetic resonance imaging

Outcome Measures

Primary Outcomes (2)

  • Frontolimbic neural circuit activation and connectivity

    Task-induced activity in frontolimbic neural circuits measured with fMRI. Core regions of interest are: ventral prefrontal cortex, dorsal prefrontal cortex, inferior frontal gyrus, insula, and dorsal anterior cingulate cortex.

    Pre-treatment, Post-treatment, and 6-months follow-up.

  • Suicidality

    Self-reported suicide ideation, intent, behaviors and urges will be repeatedly assessed throughout the protocol using the Self-Injurious Thoughts and Behaviors Interview-Revised (SITBI-R), Beck's Scale for Suicidal Ideation (SSI), Lethality Rating Scale, and Suicide Cognitions Scale - Revised (SCS-R).

    Pre-treatment, Post-treatment, 1-week post-intervention, monthly post-intervention, and 6-months post-intervention.

Secondary Outcomes (2)

  • Markers of negative affectivity

    Pre-treatment, Post-treatment, and 6-months follow-up.

  • Mood and psychiatric symptoms

    Pre-treatment, Post-treatment, 1-week post-intervention, monthly post-intervention, and 6-months post-intervention.

Study Arms (3)

Control

NO INTERVENTION

Individuals who have not experienced suicidal ideation will not complete a suicide intervention.

Crisis Response Planning (CRP)

EXPERIMENTAL

The crisis response planning (CRP) session will last between 30 minutes to 1-hour. It will occur face-to-face with a trained study therapist. The CRP session involves the following standard suicide intervention strategies: supportive listening, provision of crisis resources, and referral to a mental health professional (if not already established). The CRP active component involves a collaborative process in which the therapist invites the patient to share the events, symptoms, and contextual factors leading up to and surrounding the participant's suicidal crisis. Next, the patient and therapist identify the patient's personal warning signs for an emotional crisis, self-management coping skills, patient's reasons for living, and sources of social support. These components are written, by the patient, on an index card. The index card serves as a concrete reference for patients in the real-world.

Behavioral: Crisis Response Planning

Crisis Risk Counseling

ACTIVE COMPARATOR

The crisis risk counseling session will last between 30 minutes to 1-hour. It will occur face-to-face with a trained study therapist. It will include the following standard suicide intervention strategies: supportive listening, provision of crisis resources, and referral to a mental health professional (if not already established). The therapist will conduct a semi-structured suicide risk assessment interview, after which subjects will complete a self-guided safety plan worksheet. The worksheet takes approximately 10-minutes to complete and will be done independently.

Behavioral: Crisis Risk Counseling

Interventions

Individuals complete an experimental collaborative suicide intervention.

Crisis Response Planning (CRP)

Individuals complete a standard crisis risk management intervention.

Crisis Risk Counseling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Generally medically and neurologically healthy
  • Age 18 years or older at the time of consent
  • Willing and able to give informed consent
  • Individuals in the acutely suicidal group: endorse current suicide intent as indicated by a total score of 5 or greater on the Beck's Scale for Suicidal Ideation.

You may not qualify if:

  • Medical or neurologic condition or neurocognitive dysfunction that would interfere with the study
  • Current or past manic/hypomanic episode, schizophrenia, or psychotic symptoms
  • Deafness in either ear
  • Currently pregnant or trying to become pregnant
  • Electroconvulsive therapy (ECT) within the past 6 months
  • Current moderate to severe substance use disorder
  • Lack of fluency in English
  • Positive alcohol breathalyzer test and/or acute drug intoxication the day of the fMRI scans
  • Unwilling or unable to sign the informed consent document
  • Under 18 years old at the time of enrollment
  • Traumatic brain injury from a suicide attempt or another event
  • Presence of ferrous-containing metals within the body
  • Inability to tolerate small, enclosed spaces without significant anxiety
  • Individuals enrolled as controls: no lifetime history of any DSM-5 disorder
  • Individuals enrolled as controls: no lifetime history of suicide ideation or intent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio State University

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

SuicideSuicide Prevention

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Stephanie Gorka, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 10, 2022

First Posted

March 11, 2022

Study Start

July 28, 2021

Primary Completion

March 5, 2026

Study Completion

March 5, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

De-identified data, including fMRI, startle eyeblink, and behavior, from this project will be submitted to the NIMH Data Archive (NDA) at the subject level along with appropriate supporting documentation to enable efficient use of the data by the research community. We will follow instructions as discussed in the NIMH Data Archive Data Sharing Terms and Conditions. We will follow the two-tier procedure described in the guidelines: 1. Raw continuous fMRI recordings will be submitted in standard formats (Matlab mat format, DICOM format and NIFTI format). Experimental condition information will be supplied in text format along with other critical information. 2. Analyzed data (BOLD data, BOLD-startle eyeblink data) associated with a manuscript will be shared as soon as possible, and at the latest, at the time of publication of the manuscript. These data may be accompanied, if applicable, by other data such as behavioral data, supplied in text format.

Time Frame
The data, as outlined above, will be submitted to the NIMH Data Archive biannually per NIMH requirements throughout the duration of the study.
More information

Locations